Clinical trials
Stress Disorders, Post-Traumatic trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 3 |
| 2011 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 6 |
| Unknown status | 6 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arkin | 4 |
| VU University of Amsterdam | 3 |
| ARQ National Psychotrauma Centre | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Erasmus Medical Center | 2 |
| Reinier van Arkel | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Christiaan Vinkers | 1 |
| Geestelijke Gezondheidszorg Eindhoven (GGzE) | 1 |
| Iris Sommer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stress Disorders, Post-Traumatic | 30 |
| Wounds and Injuries | 5 |
| Anxiety Disorders | 4 |
| Personality Disorders | 2 |
| Substance-Related Disorders | 2 |
| Agoraphobia | 1 |
| Anemia, Sickle Cell | 1 |
| Borderline Personality Disorder | 1 |
| Chronic Disease | 1 |
| Combat Disorders | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.